ČESKÁ UROLOGIE / CZECH UROLOGY – 2 / 2019

113 PŘEHLEDOVÝ ČLÁNEK Ces Urol 2019; 23(2): 101–113 40. Wagstaff KE, Wooodhouse CRJ, Rose GA, Duffy PG, Ransley PG. Blood and urine analysis in patients with intestinal bladders Br J Urol 1991; 68: 311–316. 41. Fontaine E, Leaver R, Woodhouse CRJ. The effect of intestinal urinary reservoir on renal function: a ten year follow‑up study. BJU Int 2000; 86: 195–198. 42. Riedmiller H, Gerharz EW, Kohl U, Weingartner K. Continent urinary diversion in preparation for renal transplantation: a staged approach. Transplantation 2000; 70: 1713–1717. 43. Palmer LS, Franco I, Kogan S, et al. Urolithiasis in children following augmentaation cystoplasty. J Urol 1993; 150: 726–729. 44. Mathoera RB, Kok DJ, Verduin CMNijman RJM. Pathological and therapeutic significanceof cellular in‑ vasion by Proteus Mirabilis in an enterocystoplasty infection stone model. Infect Immun 2002; 70: 7022–7032. 45. Hensle TW, Bingham J, Lam J, Shabsigh A. Preventing reservoir calculi after augmentation cystoplasty and continent urinary diversion: the influence of an irrigation protocol. BJU Int; 93: 585–587. 46. Husmann DA, Rathbun SR. Long‑term follow up of enteric bladder augmentations: risk for malignancy. Journal of Pediatric Urology 2008; 4: 381–385. 47. Biardeau X, Chartier‑Kastler E, Roupret M, Phé V. Risk of malignancy after augmentation cystoplasty: a systematic review. Neurourology and Urodynamics 2016; 35: 675–682. 48. Husmann DA. Mortality following augmentation cystoplasty: a transitional urologist’s viewpoint. Journal of Pediatric Urology 2017; 13: 358–364. 49. Catellan M, Gosalbez R, Perez‑Brayfield M, et al. Tumor in bladder reservoir after gastrocystoplasty. J Urol 2007; 178 (4 Pt 2): 1771–1774. 50. Vemulakonda VM, Lendvay TS, Shnorhavorian M, et al. Metastatic adenocarcinoma after augmen‑ tation gastrocystoplasty. J Urol 2008; 179(3): 1094–1096.